Download PDF
Aktuelle Urol 2020; 51(04): 383-396
DOI: 10.1055/a-1081-7963
Operative Techniken

Radikale retroperitoneale Nephrektomie

Axel Heidenreich
› Further Information
Also available at
    Permissions and Reprints
Indikationen

  • maligne Nierentumoren > 7 cm bei gesunder Gegenniere

  • zentral gelegene Nierentumoren bei gesunder Gegenniere

  • fehlender Nachweis eines V.-cava-Thrombus ≥ Level 2

  • zytoreduktive Chirurgie vor Einleitung einer systemischen Therapie mit Multityrosinkinase-Inhibitoren oder antiangiogenetischen Medikamenten bei metastasiertem Nierenzellkarzinom und bei guter Prognose

  • sekundäre Nierentumoren, wenn Niere einziger Metastasierungsort

  • funktionslose Nieren verschiedener Genese

  • Donornephrektomie im Rahmen der Nierentransplantation



Publication History

Article published online:
29 July 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur zur weiteren Vertiefung (fakultativ)

  • 1 Corman JM, Penson DF, Kur K. et al. Comparison of complications after radical and partial nephrectomy: results from the National Veterans Administration Surgical Quality Improvement Program. BJU International 2000; 86: 782 - 789
    PubMedGoogle Scholar
  • 2 Hinman Jr. F. Atlas of Urologic Surgery. 2nd ed. Philadelphia: W. B. Saunders Company; 1998: 853 - 908
    Google Scholar
  • 3 Lau WK, Blute ML, Weaver AL. et al. Matched comparison of radical nephrectomy versus nephron-sparing surgery in patients with unilateral renal carcinoma and a normal contralateral kidney. Mayo Clin Proc 2000; 75: 1236 - 1242
    CrossrefPubMedGoogle Scholar
  • 4 Lerner SE, Hawkins CA, Blute ML. et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 2002; 167: 884 - 889
    CrossrefPubMedGoogle Scholar
  • 5 Ohlmann CH, Ozgür E, Schrader AJ. et al. Detection of circulating tumor cells in patients with renal cell carcinoma by reverse transcriptase polymerase chain reaction for G250/MNCA-9: results of a prospective trial. Urol Oncol 2006; 24: 287 - 293
    CrossrefPubMedGoogle Scholar
  • 6 Ljungberg B, Bensalah K, Canfield S. et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015; 67: 913-924
    CrossrefPubMedGoogle Scholar
  • 7 Escudier B, Porta C, Schmidinger M. ESMO Guidelines Working Group. et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014; 25 (Suppl. 03) iii49-56
    CrossrefPubMedGoogle Scholar